Literature DB >> 203677

The effect of age on neuromuscular transmission.

S S Kelly.   

Abstract

1. Resting membrane potentials (RMPs), spontaneous miniature end-plate potentials (m.e.p.p.s), and evoked end-plate potentials (e.p.p.s) were recorded in phrenic nerve-hemidiaphragm preparations from rats at ages from 11 to 375 days. 2. The mean RMP increased from -64.1 +/- 1.2 mV (mean +/- S.E.) at age 11 days to -71.3 +/- 1.0 mV at age 30 days, after which there was no significant change with age. 3. The mean amplitude of m.e.p.p.s decreased from 1.088 +/- 0.070 mV at 11 days of age to 0.405 +/- 0.030 mV at 175 days of age, after which there was no significant change. 4. There was a rpaid, large increase in the frequency of m.e.p.p.s from 0.02/sec to 0.97/sec (geometric means) between 11 and 23 days of age, followed by a slower increase to 3.19/sec at 175 days of age. Subsequently there was a decrease by 2.58/sec at 375 days of age. 5. The mean of quantum content of plateau e.p.p.s elicited at a frequency of 10 Hz increased from 20.5 quanta/e.p.p. to 169.9 quanta/e.p.p. (geometric means) between 11 and 175 days of age and then decreased to 120.4 quanta/e.p.p. at 375 days of age. 6. The mean quantum content of the first e.p.p.s of trains of e.p.p.s increased from 44.2 quanta/e.p.p. to 468.8 quanta/e.p.p. (geometric means) between 11 and 175 days of age and then decreased to 358.1 quanta/e.p.p. at 375 days of age. 7. The calculated safety factor of neuromuscular transmission increased with age up to 110-175 days and subsequently decreased. 8. The change in all the above parameters occurred most rapidly in the first 6 weeks of life. The rapidity of these changes indicates that great care must be taken to ensure that control and experimental animals are adequately matched according to age, especially when rats weighing less than about 300 g are used.

Entities:  

Mesh:

Year:  1978        PMID: 203677      PMCID: PMC1282476          DOI: 10.1113/jphysiol.1978.sp012133

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  21 in total

1.  The effect of membrane capacitance on non-linear summation of synaptic potentials.

Authors:  A R Martin
Journal:  J Theor Biol       Date:  1976-06       Impact factor: 2.691

2.  A comment on Martin's relation.

Authors:  C F Stevens
Journal:  Biophys J       Date:  1976-08       Impact factor: 4.033

3.  Binomial analysis of quantal transmitter release at glycerol treated frog neuromuscular junctions.

Authors:  M D Miyamoto
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

4.  Spontaneous transmitter release from nerve endings and contractile properties in the soleus and diaphragm muscles of senile rats.

Authors:  F Vyskocil; E Gutmann
Journal:  Experientia       Date:  1972-03-15

5.  Age changes in cross striated muscle of the rat.

Authors:  E Gutmann; V Hanzlíková; F Vysokocil
Journal:  J Physiol       Date:  1971-07       Impact factor: 5.182

6.  Correlation between nerve terminal size and transmitter release at the neuromuscular junction of the frog.

Authors:  M Kuno; S A Turkanis; J N Weakly
Journal:  J Physiol       Date:  1971-03       Impact factor: 5.182

7.  Choline acetyltransferase activity in rat skeletal muscles during postnatal development.

Authors:  S Tucek
Journal:  Exp Neurol       Date:  1972-08       Impact factor: 5.330

8.  Biometric analyses of normal skeletal muscle.

Authors:  M J Moore; J J Rebeiz; M Holden; R D Adams
Journal:  Acta Neuropathol       Date:  1971       Impact factor: 17.088

9.  The margin of safety of neuromuscular transmission.

Authors:  W D Paton; D R Waud
Journal:  J Physiol       Date:  1967-07       Impact factor: 5.182

10.  The histogenesis of rat intercostal muscle.

Authors:  A M Kelly; S I Zacks
Journal:  J Cell Biol       Date:  1969-07       Impact factor: 10.539

View more
  27 in total

1.  Active zone density is conserved during synaptic growth but impaired in aged mice.

Authors:  Jie Chen; Takafumi Mizushige; Hiroshi Nishimune
Journal:  J Comp Neurol       Date:  2012-02-01       Impact factor: 3.215

2.  Pharmacological aspects of neuromuscular transmission in the isolated diaphragm of the dystrophic (Rej 129) mouse.

Authors:  J B Harris; R R Ribchester
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

3.  Neuromuscular transmission at newly formed neuromuscular junctions in the regenerating soleus muscle of the rat.

Authors:  B D Grubb; J B Harris; I S Schofield
Journal:  J Physiol       Date:  1991-09       Impact factor: 5.182

4.  Changes in aging mouse neuromuscular junctions are explained by degeneration and regeneration of muscle fiber segments at the synapse.

Authors:  Yue Li; Young il Lee; Wesley J Thompson
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

5.  TGF-beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size.

Authors:  Sitt Wai Fong; Ian S McLennan; Andrew McIntyre; Jayne Reid; Kathleen I J Shennan; Guy S Bewick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

6.  The action of thallium acetate on phasic transmitter release in the mouse neuromuscular junction.

Authors:  H Wiegand; H Lohmann; S V Chandra
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

7.  The effect of altered peripheral field on motoneurone function in developing rat soleus muscles.

Authors:  M B Lowrie; R A O'Brien; G Vrbová
Journal:  J Physiol       Date:  1985-11       Impact factor: 5.182

8.  Action potential generation in rat slow- and fast-twitch muscles.

Authors:  S J Wood; C R Slater
Journal:  J Physiol       Date:  1995-07-15       Impact factor: 5.182

Review 9.  Active zones of mammalian neuromuscular junctions: formation, density, and aging.

Authors:  Hiroshi Nishimune
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

10.  Altered developmental changes of neuromuscular junction in hypo- and hyperthyroid rats.

Authors:  K Kawa; K Obata
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.